Orthofix Medical Inc. Restructuring and Related Cost, Cost Incurred to Date
Orthofix Medical Inc. (OFIX) had Restructuring and Related Cost, Cost Incurred to Date of $2.00 million as of 2017-06-30, per its 10-Q filed 2017-08-07.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 · last filed 2017-08-07
- 2017-06-30: Restructuring and Related Cost, Cost Incurred to Date $2.00M.
- 2017-03-31: Restructuring and Related Cost, Cost Incurred to Date $1.70M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date |
|---|---|
| 2017-06-30 | $2.00M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $1.70M 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |